Galapagos · 1 week ago
Manager Transactions
Galapagos is a company headquartered in Belgium, expanding its executive team in the U.S. with a mission to advance transformative clinical-stage assets in immunology and oncology. The Manager Transactions will support the Chief Business Officer and Vice President of Transactions in business development activities, focusing on financial modeling and valuation to inform transaction decision-making.
BiopharmaBiotechnologyClinical TrialsHealth CareMedical
Responsibilities
Provide day-to-day support on transaction workstreams under the leadership of the Vice President Transactions
Develop and maintain complex financial models to evaluate companies, assets, partnerships, and transaction structures across multiple scenarios
Conduct valuation and sensitivity analyses to inform deal strategy and recommendations
Manage specific workstreams within the transaction process, including due diligence coordination and information gathering
Draft high-quality presentations and supporting materials for internal stakeholders, including management committee and board reviews
Work closely with cross-functional teams to integrate inputs into financial models and transaction analyses
Support the preparation of business cases and transaction documentation with analytical and strategic insights
Partner with external advisors (bankers, consultants, lawyers) to ensure robust execution of deal processes
Qualification
Required
Senior Analyst or Associate-level experience in investment banking, private equity, or consulting, ideally with exposure to healthcare or biopharma transactions
Strong technical skills in financial modeling, valuation, and analysis of company and asset-level economics
Solid understanding of transaction processes, including due diligence, process management, and deal structuring
Excellent analytical and problem-solving skills, with the ability to manage multiple priorities in a fast-paced environment
Strong communication and presentation skills, with the ability to convey complex analyses clearly to senior stakeholders
Highly organized, detail-oriented, and proactive, with a collaborative mindset
Benefits
Participation in Galapagos’ performance bonus plan
Comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support important moments in life
Company
Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Funding
Current Stage
Public CompanyTotal Funding
$5.45BKey Investors
Gilead SciencesVan Herk VenturesThe Institute for the Promotion of Innovation by Science and Technology in Flanders
2019-07-14Post Ipo Equity· $5.1B
2018-09-17Post Ipo Equity· $300M
2015-05-14IPO
Recent News
2026-01-06
2026-01-06
2026-01-06
Company data provided by crunchbase